Financhill
Back

Clearside Biomedical Quote, Financials, Valuation and Earnings

Clearside Biomedical Price Quote

$1.03
+0.01 (+-1.9%)
(Updated: November 22, 2024 at 5:18 AM ET)

Clearside Biomedical Key Stats

Sell
31
Clearside Biomedical (CLSD) is a Sell

Day range:
$1.01 - $1.08
52-week range:
$0.92 - $2.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.33
P/B ratio:
0%

Volume:
224.9K
Avg. volume:
485.8K
1-year change:
7.37%
Market cap:
$77.4M
Revenue:
$8.2M
EPS:
$-0.45

How Much Does Clearside Biomedical Make?

Is Clearside Biomedical Growing As A Company?

  • What Is Clearside Biomedical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Clearside Biomedical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Clearside Biomedical Stock Price Performance

What Is Clearside Biomedical 52-Week High & Low?

Clearside Biomedical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Clearside Biomedical?

Is Clearside Biomedical Cash Flow Positive?

  • What Is CLSD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$18.9M
  • What Is Clearside Biomedical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.1M
  • What Is Clearside Biomedical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$10.1M

Clearside Biomedical Return On Invested Capital

Data Unavailable

Clearside Biomedical Earnings Date & Stock Price

Clearside Biomedical Competitors

  • Who Are Clearside Biomedical's Competitors?
    Below is a list of companies who compete with Clearside Biomedical or are related in some way:
    • Atara Biotherapeutics Inc (ATRA)
    • Perspective Therapeutics Inc (CATX)
    • Crinetics Pharmaceuticals Inc (CRNX)
    • Corvus Pharmaceuticals Inc (CRVS)
    • Viking Therapeutics Inc (VKTX)

Clearside Biomedical Dividend Yield

Clearside Biomedical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.54%
Revenue: 20.84% 744.86%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 488.24%

Major Shareholders

  • How many CLSD shares are owned by institutional investors?
    15.3M CLSD shares are owned by institutional investors
  • How many CLSD shares are owned by insiders?
    6.6M CLSD shares are owned by insiders